News
-
-
PRESS RELEASE
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
Prolocor, Inc. announces publication of results from a confirmatory 800 patient ACS trial in JACC, showing a >2-fold predictive value for heart attack, stroke, and death. The Prolocor pFCG® test supports individualized antiplatelet therapy -
-
-
-
-
-
-
-